Helicobacter pylori infection and immune thrombocytopenia in children
Meng Zhang,Xuan Zhou,Jingyao Ma,Wen-wen He,Yan Su,Jin Jiang,Rui Zhang,Li Zhang,Jun J. Yang,Zhenping Chen,Jie Zheng,Jie Ma,Liqiang Zhang
DOI: https://doi.org/10.3760/CMA.J.ISSN.2095-428X.2014.07.011
2014-04-05
Abstract:Objective
To investigate the correlation between Helicobacter pylori (Hp) infection and immune thrombocytopenia (ITP), and to provide the basis to explore its pathogenicity and suggest effective treatment.
Methods
Clinical data of children with incipient ITP admitted to Hematology-Oncology Center of Beijing Children's Hospital Affiliated to Capital Medical University from May 2009 to Dec.2011 were collected and followed up for at least 1 year. Hp was routinely screened at admission to hospital.According to the occurrence of Hp co-infection, patients were divided into Hp positive group and Hp negative group for observations of: 1.the clinical characteristics: age, gender, severity of bleeding and level of platelet counts decreased; 2.the treatment response and outcomes of ITP, and further analysis of whether Hp infection was the relevant high risk factor; 3.the influence of Hp eradication on the prognosis of ITP.
Results
There were 221 cases of first onset ITP, 52 cases (23.5%) with Hp infection (Hp positive group) and 169 cases (76.5%) with out Hp infection (Hp negative group). 1.There was significant difference between Hp positive group and Hp negative group in ages(Z=-4.996, P=0.000). The patients with Hp infection were older. But there was no difference in gender (χ2=0.080), severity of bleeding (χ2=0.459) and level of platelet counts decreasing(χ2=1.317)(all P>0.05).2.One hundred and seventy-three cases were followed up for more than 1 year. The median time of complete response in Hp infection group was 4 months(95%CI 1.56-6.44), but was 2 months (95%CI 1.77-2.23) in the other group. There was statistical difference in the rate of complete response (χ2=4.543, P=0.033) and chronic disease evolution (χ2=8.574, P=0.036) between Hp positive group and Hp negative group, but there was no difference after the age adjustment (P>0.05).3.Forty-five Hp positive ITP cases were followed up more for than 1 year. After Hp eradication treatment, 33 cases succeeded, but 12 cases failed. The outcomes of ITP was statistically different between Hp eradicated group and Hp un-eradicated group(χ2=4.448, P=0.035), but there was no statistical difference in therapeutic response between them(χ2=1.452, P=0.228). There was no recurrent ITP case in the 33 children with Hp eradication, but 4 recurrent cases(33.3%, 4/12 cases)were found in the 12 un-eradicated cases. The results suggested that Hp eradication therapy did not obviously enhance the therapeutic effect on children with ITP, but could be helpful to shorten the duration of ITP and decrease the relapse rate.
Conclusions
Although affected by the epidemiology of Hp infection, the ITP children with Hp infection are older, and the other characteristics like gender, severity of bleeding and level of platelet counts decreasing between the groups with and without Hp infection have no difference. And after the age adjustment, Hp infection is not the risk factor for the worse result and progress of ITP children, but the Hp eradication can be helpful in the reduction of ITP chronic progress and relapse.
Key words:
Immune thrombocytopenia; Helicobacter pylori infection; Child
Medicine